Assessing Centene’s (CNC) Valuation After a Sharp 3-Month Rebound and Ongoing Share Price Weakness

Simply Wall St.09:36

Centene (CNC) has quietly drifted lower this week, even after a strong past 3 months. That disconnect is catching some investors’ attention as they reassess what the recent rebound really implies. See...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589495078?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/26273-main-header/1756252774034","is_english":true,"pubTime":"2025-12-06 09:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589495078","market":"sg","top_or_hot":-1,"title":"Assessing Centene’s (CNC) Valuation After a Sharp 3-Month Rebound and Ongoing Share Price Weakness","media":"Simply Wall St.","content":"<div>\n<p>Centene (CNC) has quietly drifted lower this week, even after a strong past 3 months. That disconnect is catching some investors’ attention as they reassess what the recent rebound really implies. See...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/assessing-centenes-cnc-valuation-after-a-sharp-3-month-rebou\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Centene’s (CNC) Valuation After a Sharp 3-Month Rebound and Ongoing Share Price Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Centene’s (CNC) Valuation After a Sharp 3-Month Rebound and Ongoing Share Price Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-06 09:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/assessing-centenes-cnc-valuation-after-a-sharp-3-month-rebou><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Centene (CNC) has quietly drifted lower this week, even after a strong past 3 months. That disconnect is catching some investors’ attention as they reassess what the recent rebound really implies. See...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/assessing-centenes-cnc-valuation-after-a-sharp-3-month-rebou\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE0034235188.USD","symbol_name":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/assessing-centenes-cnc-valuation-after-a-sharp-3-month-rebou","article_id":"2589495078","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/26273-main-header/1756252774034"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/assessing-centenes-cnc-valuation-after-a-sharp-3-month-rebou","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2589495078","pubTimestamp":1764984999,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Centene (CNC) has quietly drifted lower this week, even after a strong past 3 months. That disconnect is catching some investors’ attention as they reassess what the recent rebound really implies.\nSee our latest analysis for Centene.\nEven with a sharp 32.3% 3 month share price rebound, the stock is still nursing a heavy year to date share price loss, and multi year total shareholder returns remain deeply negative. This suggests sentiment is stabilising rather than fully turning bullish.\nIf...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","BK4588":"碎股","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","BK4585":"ETF&股票定投概念","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","CNC":"康西哥","BK4154":"管理型保健护理","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC"},"translate_title":"在连续3个月大幅反弹和股价持续疲软后评估Centene(CNC)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNC":1.5},"content_text":"Centene (CNC) has quietly drifted lower this week, even after a strong past 3 months. That disconnect is catching some investors’ attention as they reassess what the recent rebound really implies. See our latest analysis for Centene. Even with a sharp 32.3% 3 month share price rebound, the stock is still nursing a heavy year to date share price loss, and multi year total shareholder returns remain deeply negative. This suggests sentiment is stabilising rather than fully turning bullish. If Centene has you rethinking your healthcare exposure, it could be worth scanning other potential opportunities across healthcare stocks to see how peers and adjacent names are lining up on growth and resilience. With earnings rebounding but the share price still far below past highs and only a small discount to analyst targets, the key question now is simple: is Centene a contrarian opportunity, or is future growth already priced in? AdvertisementMost Popular Narrative: 4% Undervalued With Centene last closing at $38.34 against a narrative fair value of $39.94, the current share price sits just below that intrinsic marker, framing a tight valuation gap that investors are now dissecting more closely.  Bullish analysts point to sustained margin recovery in Marketplace and Medicaid as the key driver of outsized EPS growth over 2026 and 2027, arguing that recent pricing actions and rate refilings are now better aligned with risk adjustment mechanics and evolving risk pools, and that updated FY25 and early 2026 commentary supports a multi year earnings re rating story.  Read the complete narrative. Curious how modest revenue growth, slim but improving margins and a lower forward multiple can still add up to a higher fair value? The most followed narrative leans heavily on stable earnings power and disciplined share count reduction to bridge that gap. Want to see the exact assumptions behind those future profits and why they justify a richer valuation than today? Result: Fair Value of $39.94 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, policy uncertainty around ACA subsidies and volatile Medicaid medical costs could quickly undermine margin recovery hopes and force analysts to revisit today’s assumptions. Find out about the key risks to this Centene narrative.  Build Your Own Centene Narrative If you see things differently or want to stress test the numbers yourself, you can build a custom view in minutes: Do it your way. A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Centene. Looking for more investment ideas? Before you move on, you may wish to explore focused stock ideas from the Simply Wall St screener so that potential opportunities do not slip past you.  Consider capturing momentum in innovation by scanning these 26 AI penny stocks, where cutting edge businesses are working to commercialise real world AI solutions. You can review these 15 dividend stocks with yields > 3% to explore companies that aim to balance dividend yield with sustainable payout potential. You can also analyse these 906 undervalued stocks based on cash flows to find companies that are currently assessed as trading below their estimated cash flow value.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589495078","isCrawlerRequest":true}